Abstract
Effective translation of evidence from clinical trials into clinical practice requires the enrolment of diverse, representative trial populations. However, this diversity is still often lacking, with negative clinical implications for under-served groups. Changes are needed to research practices and the broader research landscape to correct this problem.
Original language | English |
---|---|
Number of pages | 0 |
Journal | Nature Reviews Neurology |
Volume | 0 |
Issue number | 0 |
DOIs | |
Publication status | Published - 29 Jun 2022 |